Clinical Trial Update: To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD [Phase 3]

View source ↗

Summary

Phase 3 trial of 1% OPA-15406 ointment in adults with atopic dermatitis demonstrated superiority to vehicle.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• OPA-15406 ointment (OPA-15406)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: COMPLETED